US Patent 9358299 17-hydroxyprogesterone ester-containing oral compositions and related methods
Patent 9358299 was granted and assigned to Lipocine Inc. on June, 2016 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 9358299 17-hydroxyprogesterone ester-containing oral compositions and related methods
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
